Signaling pathways associated with lncRNAs regulation of EMT. (A) The positive feedback loop and Wnt/β-catenin signaling pathway. First, DLGAP1-AS1 (47) promoted EMT through a positive feedback loop. Mechanistically, 1) DLGAP1-AS1 sponged and sequestered miR-26a-5p and miR-26b-5p to upregulate IL-6. IL-6 stimulated the JAK2/STAT3 signaling pathway, which conversely promoted DLGAP1-AS1. 2) DLGAP1-AS1 activated the Wnt/β-catenin pathway by upregulating the downstream CDK8 and LRP6 of miR-26a/b-5p. Second, HCCL5 (60) accelerated EMT by upregulating the expression of Snail, Slug, ZEB1, and Twist1. In turn, HCCL5 was transcriptionally driven by ZEB1. Third, lncRNA-NEF (61) was transcriptionally activated by FOXA2 and, in turn, activated its neighboring gene FOXA2. LncRNA-NEF interacted with β-catenin to increase the binding of GSK3β with β-catenin, leading to the suppression of Wnt/β-catenin signaling. Fourth, lncRNA FOXD2-AS1 (62) induced by EGR1 promoted the EMT process by binding with EZH2 to epigenetically silence the DKK1 gene and activating the Wnt/β-catenin axis. Fifth, CRNDE-promoted Wnt/β-catenin signaling pathway activity was inhibited by CRNDE (63) knockdown. Unfortunately, the paper did not clarify how CRNDE reduces the level of signaling pathway-related proteins. (B) The PI3K/AKT/mTOR signaling pathway. First, STAT3-induced lncRNA CASC11 (64) promotes EMT by binding with the enhancer of EZH2 to epigenetically silence PTEN and activate the PI3K/AKT axis. Second, lncRNA PTTG3P (65) promotes EMT by upregulating PTTG1 and activating the PI3K/AKT axis. Third, TMPO-AS1 (42) upregulated the oncogene FOXK1 by sponging miR-329-3p to activate the AKT/mTOR signaling pathway. (C) The JAK2/STAT3 signaling pathway and MEK/ERK signaling pathway. First, HOST2 (66) enhanced EMT by upregulating the JAK2-STAT3 signaling pathway. Second, FEZF1-AS1 (67) increased EMT via the JAK2/STAT3 signaling pathway. Third, HOXA-AS3 (68) upregulated BMP1 by sponging miR-29c, thus activating the MEK/ERK signaling pathway to enhance EMT. Fourth, the DRHC/MYBBP1A/C-Myb (69) complex with C-Myb inhibited the MEK/ERK signaling pathway and finally inhibited EMT. The corresponding references were also indicated under the lncRNA names on the figure.